Skip to main content

Avricore Health looks to continue positive growth in 2023 after success in 2022

Avricore Health CEO Hector Bremner joined Proactive's Steve Darling with an update on the company's 2022 performance and the goals it has set for 2023.

Bremner told Proactive more about Avricore's key HealthTab offering and the scaling it saw in 2022. He also shared his vision for 2023, which includes further expansion of HealthTab with current partners, international expansion, and revenue growth and profitability.

Contact Details

Proactive Studio

+1 347-449-0879

na-editorial@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.45
+3.18 (1.55%)
AAPL  272.18
+6.00 (2.25%)
AMD  213.99
+17.39 (8.84%)
BAC  50.26
-0.81 (-1.60%)
GOOG  311.29
-0.40 (-0.13%)
META  638.67
+1.42 (0.22%)
MSFT  388.56
+4.09 (1.06%)
NVDA  193.57
+2.02 (1.06%)
ORCL  145.97
+4.66 (3.30%)
TSLA  410.45
+10.62 (2.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.